Kathleen Liu is Professor of Medicine and Anesthesia in the Divisions of Nephrology and Critical Care Medicine at the University of California, San Francisco. She is the Medical Director of the Medical Intensive Care Unit and the Apheresis/Hemodialysis Unit. Dr. Liu’s research has focused on the acute respiratory distress syndrome and acute kidney injury, with a major focus on clinical trials. In the area of acute kidney injury, she has also had a longstanding interest in long term outcomes for patients with acute kidney injury. She was a Steering Committee Member for the NIDDK funded Assessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) study and is the current external steering committee chair for the NIDDK-funded Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) study. Dr. Liu is the co-principal investigator for LIBERATE-D, a trial focused on strategies to wean dialysis after dialysis-requiring AKI.